Leállítva1. fázis
Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases
A legfontosabb adatok
- Ki végzi
- Yale University
- Hol
- New Haven (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Leállítva
- Fázis
- 1. fázis
- Résztvevők
- 7 fő vett részt
- Kezdés
- 2023. febr. 21.
- Befejezés
- 2024. jan. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- adnectin 18F-BMS-986192 Head and Neck Cancer
- adnectin 18F-BMS-986192 Brain Metastases
- A regiszteradat frissítve
- 2024. február 15.
- Miért állt le
- PI changed institutions
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 27 feltétel megnézéseKevesebb
Ki vehet részt
- Patients with resectable squamous cell carcinoma of the oropharynx (HPV positive and HPV negative)
- Resectability will be confirmed by a surgical co-investigator
- If available, HPV-association determined by institutional p16 testing (CINtec antibody demonstrating strong and diffuse nuclear and cytoplasmic staining is at least 70% of cells)
- Absolute neutrophil count (ANC) > 1500/microliter, absolute lymphocyte count (ALC) >1000/microliter, hemoglobin > 9 g/dl, platelets > 100,000/microliter
- aspartate aminotransferase (AST) and alanine transaminase (ALT) < 5 x upper limit of normal. Bilirubin < 1.5 x upper limit of normal
- Albumin > 0 g/dl
- Creatinine < 5 x upper limit of normal
- Women of child-bearing potential must have a negative serum pregnancy test within 7 days prior to treatment
- Patients with brain metastases
- Tumor size equal or greater than 1 cm
- Resectability or need for laser interstitial thermal therapy (LITT) will be confirmed by a surgical co-investigator
- Absolute neutrophil count (ANC) > 1500/microliter, absolute lymphocyte count (ALC) >1000/microliter, hemoglobin > 9 g/dl, platelets > 100,000/microliter
- AST and ALT < 5 x upper limit of normal. Bilirubin < 1.5 x upper limit of normal
- Albumin > 0 g/dl
- Creatinine < 5 x upper limit of normal
- Women of child-bearing potential must have a negative serum pregnancy test within 7 days prior to treatment
Ki nem vehet részt
- Medical contraindication to surgery
- Concomitant invasive malignancy, or malignancy within 2 years except for hormonally responsive breast or prostate cancer, resected non-melanoma skin cancer, resected uterine cervical carcinoma
- Prior systemic therapy, radiation or gross resection for the tumor under study
- Receipt of other systemic therapy including investigational agents, radiation or gross resection for treatment of the tumor under study
- Medical contraindication to brain surgery
- Full dose anticoagulation
- Inability to give informed consent
- Women may not be pregnant or breast-feeding
- Full dose anticoagulation
- Inability to give informed consent
- Women may not be pregnant or breast-feeding
Helyszínek itt: Egyesült Államok
- Yale University PET CenterNew Haven, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study aims to determine the feasibility of non-invasive quantitative PD-L1 measurement using [a novel PD-L1 positron emission tomography (PET) tracer and perform immunohistochemistry based measurement of PD-L1 levels within resected lesions in head and neck cancer and brain metastases.
A vizsgálat 2 csoportja
- Head and neck cancerA vizsgált kezelés
Participants with head and neck squamous cell carcinoma who plan to undergo tumor resection and lymph node resection.
Kezelés: adnectin 18F-BMS-986192 Head and Neck Cancer
- Brain MetastasesA vizsgált kezelés
Participants with metastases to the brain from melanoma, lung cancer, breast cancer.
Kezelés: adnectin 18F-BMS-986192 Brain Metastases
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Pilot Study of Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases
- A regiszteradat frissítve
- 2024. február 15.